| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $608K | +139.6% |
| Cost of Revenue | $385K | -18.9% |
| Gross Profit | $223K | +200.8% |
| R&D Expense | $5.0M | +620.8% |
| SG&A Expense | $5.0M | +18.5% |
| Operating Income | -$9.7M | -88.5% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$8.0M | -108.6% |
| Income Tax | $250 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | -22.6% |
| Short-term Investments | $1.7M | — |
| Accounts Receivable | $487K | +110.4% |
| Inventory | $443K | -5.0% |
| Current Assets | $5.4M | -25.6% |
| Total Assets | $5.8M | -26.0% |
| Current Liabilities | $1.7M | -41.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | -24.3% |
| Capital Expenditures | $104K | +80.1% |
| Investing Cash Flow | -$1.9M | -1530.1% |
| Financing Cash Flow | $7.1M | +8.9% |
| Free Cash Flow | -$5.8M | -25.0% |
| +0.0% |
| Net Income | -$7.9M | -111.0% |
| EPS (Basic) | -$18.55 | -1773.7% |
| EPS (Diluted) | -$18.55 | -1773.7% |
| Long-term Debt |
| $150K |
| +0.0% |
| Total Liabilities | $1.8M | -39.6% |
| Stockholders' Equity | $4.0M | -17.1% |